Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Complex roles of tissue inhibitors of metalloproteinases in cancer

Abstract

Matrix metalloproteinases (MMPs) is tightly associated with extracellular matrix (ECM) turnover, which plays a very active role in tumor invasion and metastasis. Tissue inhibitors of metalloproteinases (TIMPs) plays a critical role in the homeostasis of ECM by regulating the activity of MMPs. TIMPs are well-known for their ability to inhibit MMP activity thereby inhibiting tumor growth and metastasis. However, many evidences suggest that TIMPs are multifunctional proteins, which regulate cell proliferation, apoptosis, proMMP-2 activation, and angiogenesis. These effects may be through MMP-dependent or MMP-independent pathways. Recent data indicate that TIMPs have many paradoxical roles in tumorigenesis. In particular, both inhibitory effect and stimulatory effect on tumorigenesis have been demonstrated in many animal models in which TIMPs were overexpressed in cancer cells or in mice. Elevated TIMP levels are reported in association with cancer progression and identified as poor prognostic indicators in several human tumor types. Herein, we review the complex roles of TIMPs in cancer growth and metastasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG . 1991 J. Natl. Cancer Inst. 83: 775–779

  • Ahonen M, Baker AH, Kahari VM . 1998 Cancer Res. 58: 2310–2315

  • Alexander CM, Howard EW, Bissell MJ, Werb Z . 1996 J. Cell Biol. 135: 1669–1677

  • Alvarez OA, Carmichael DF, DeClerck YA . 1990 J. Natl. Cancer Inst. 82: 589–595

  • Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B . 1997 Invest. Ophthalmol. Vis. Sci. 38: 817–823

  • Baker AH, George SJ, Zaltsman AB, Murphy G, Newby AC . 1999 Br. J. Cancer 79: 1347–1355

  • Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Thorpe P, Itohara S, Werb Z, Hanahan D . 2000 Nat. Cell Biol. 2: 737–744

  • Bernhard EJ, Gruber SB, Muschel RJ . 1994 Proc. Natl. Acad. Sci. USA 91: 4293–4297

  • Bertaux B, Hornebeck W, Eisen AZ, Dubertret L . 1991 J. Invest. Dermatol. 97: 679–685

  • Bigg HF, Shi YE, Liu YE, Steffensen B, Overall CM . 1997 J. Biol. Chem. 272: 15496–15500

  • Bond M, Murphy G, Bennett MR, Amour A, Knauper V, Newby AC, Baker AH . 2000 J. Biol. Chem. 275: 41358–41363

  • Boulay A, Masson R, Chenard MP, El Fahime M, Cassard L, Bellocq JP, Sautes-Fridman C, Basset P, Rio MC . 2001 Cancer Res. 61: 2189–2193

  • Brand K, Baker AH, Perez-Canto A, Possling A, Sacharjat M, Geheeb M, Arnold W . 2000 Cancer Res. 60: 5723–5730

  • Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP, Murphy G . 1998 J. Biol. Chem. 273: 871–880

  • Butler GS, Apte SS, Willenbrock F, Murphy G . 1999 J. Biol. Chem. 274: 10846–10851

  • Caterina JJ, Yamada S, Caterina NC, Longenecker G, Holmback K, Shi J, Yermovsky AE, Engler JA, Birkedal-Hansen H . 2000 J. Biol. Chem. 275: 26416–26422

  • Cao J, Drews M, Lee HM, Conner C, Bahou WF, Zucker S . 1998 J. Biol. Chem. 273: 34745–34752

  • Celiker MY, Wang M, Atsidaftos E, Liu X, Liu YE, Jiang Y, Valderrama E, Goldberg ID, Shi YE . 2001 Oncogene 20: 4337–4343

  • Cornelius LA, Nehring LC, Harding E, Bolanowski M, Welgus HG, Kobayashi DK, Pierce RA, Shapiro SD . 1998 J. Immunol. 161: 6845–6852

  • Coussens LM, Werb Z . 1996 Chem. Biol. 3: 895–904

  • Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D . 1999 Genes Dev. 13: 1382–1397

  • Coussens LM, Tinkle CL, Hanahan D, Werb Z . 2000 Cell 103: 481–490

  • Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Reich R . 1999 Gynecol. Oncol. 73: 372–382

  • Denhardt DT, Khokha R, Yagel S, Overall CM, Parhar RS . 1992 Matrix 1: Suppl 281–285

  • Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G, Reynolds JJ . 1985 Nature 318: 66–69

  • Dong Z, Kumar R, Yang X, Fidler IJ . 1997 Cell 88: 801–810

  • Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopouulos G, Moses MA . 2000 Proc. Natl. Acad. Sci. USA 97: 3884–3889

  • Fernandez HA, Kallenbach K, Seghezzi G, Grossi E, Colvin S, Schneider R, Mignatti P, Galloway A . 1999 J. Surg. Res. 82: 156–162

  • Fletcher L . 2000 Nat. Biotechnol. 18: 1138–1139

  • Fong KM, Kida Y, Zimmerman PV, Smith PJ . 1996 Clin. Cancer Res. 2: 1369–1372

  • Goss KJ, Brown PD, Matrisian LM . 1998 Int. J. Cancer 78: 629–635

  • Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE . 1996 J. Biol. Chem. 271: 30375–30380

  • Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M . 1998 J. Clin. Invest. 102: 2002–2010

  • Guedez L, McMarlin AJ, Kingma DW, Bennett TA, Stetler-Stevenson M, Stetler-Stevenson WG . 2001 Am. J. Pathol. 158: 1207–1215

  • Hammani K, Henriet P, Silbiger SM, DeClerck YA . 1996 Gene 170: 287–288

  • Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K . 1992 FEBS Lett. 298: 29–32

  • Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A . 1994 J. Cell Sci. 107: 2373–2379

  • Hernandez-Barrantes S, Shimura Y, Soloway PD, Sang QA, Fridman R . 2001 Biochem. Biophys. Res. Commun. 281: 126–130

  • Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R . 2000 J. Biol. Chem. 275: 12080–12089

  • Hewitt R, Dano K . 1996 Enzyme Protein 49: 163–173

  • Hewitt RE, Brown KE, Corcoran M, Stetler-Stevenson WG . 2000 J. Pathol. 192: 455–459

  • Hoegy SE, Oh HR, Corcoran ML, Stetler-Stevenson WG . 2001 J. Biol. Chem. 276: 3203–3214

  • Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brunner N . 2000 Clin. Cancer Res. 6: 4292–4299

  • Hoyhtya M, Fridman R, Komarek D, Porter-Jordan K, Stetler-Stevenson WG, Liotta LA, Liang CM . 1994 Int. J. Cancer 56: 500–505

  • Itoh Y, Ito A, Iwata K, Tanzawa K, Mori Y, Nagase H . 1998 J. Biol. Chem. 273: 24360–24367

  • Jiang Y, Wang M, Celiker MY, Liu YE, Sang QX, Goldberg ID, Shi YE . 2001 Cancer Res. 61: 2365–2370

  • Jones JL, Glynn P, Walker RA . 1999 J. Pathol. 189: 161–168

  • Joo YE, Seo KS, Kim HS, Rew JS, Park CS, Kim SJ . 2000 Dig. Dis. Sci. 45: 114–121

  • Karrison TG, Ferguson DJ, Meier P . 1999 J. Natl. Cancer Inst. 91: 80–85

  • Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT . 1989 Science 243: 947–950

  • Khokha R . 1994 J. Natl. Cancer Inst. 86: 299–304

  • Koshiba T, Hosotani R, Wada M, Miyamoto Y, Fujimoto K, Lee JU, Doi R, Arii S, Imamura M . 1998 Cancer 82: 642–650

  • Kossakowska AE, Urbanski SJ, Edwards DR . 1991 Blood 77: 2475–2481

  • Kruger A, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V, Harbeck N, Gansbacher B, Schemitt M . 2001 Cancer Res. 61: 1272–1275

  • Lein M, Nowak L, Jung K, Laube C, Ulbricht N, Schnorr D, Loeening SA . 1999 Ann. N Y Acad. Sci. 878: 544–546

  • Lein M, Jung K, Le DK, Hasan T, Ortel B, Borchert D, Winkelmann B, Schnorr D, Loeening SA . 2000 Prostate 43: 77–82

  • Li G, Fridman R, Kim HR . 1999 Cancer Res. 59: 6267–6275

  • Low JA, Johnson MD, Bone EA, Dickson RB . 1996 Clin. Cancer Res. 2: 1207–1214

  • Lukashev ME, Werb Z . 1998 Trends. Cell Biol. 8: 437–441

  • Luparello C, Avanzato G, Carella C, Pucci-Minafra I . 1999 Breast Cancer Res Treat. 54: 235–244

  • Masson R, Lefebvre O, Noel A, Fahime ME, Chenard MP, Wendling C, Kebers F, LeMeur M, Dierich A, Foidart JM, Basset P, Rio MC . 1998 J. Cell Biol. 140: 1535–1541

  • Matsuzawa K, Fukuyama K, Hubbard SL, Dirks PB, Rutka JT . 1996 J. Neuropathol. Exp. Neurol. 55: 88–96

  • McCarthy K, Maguire T, McGreal G, McDermott E, O'Higgins N, Duffy MJ . 1999 Int. J. Cancer 84: 44–48

  • Michael M, Babic B, Khokha R, Tsao M, Ho J, Pintilie M, Leco K, Chamberlin D, Shepherd FA . 1999 J. Clin. Oncol. 17: 1802–1808

  • Murphy AN, Unsworth EJ, Stetler-Stevenson WG . 1993 J. Cell Physiol. 157: 351–358

  • Nagasse H, Woessner Jr JF . 1999 J. Biol. Chem. 274: 21491–21494

  • Nii M, Kayada Y, Yoshiga K, Takada K, Okamoto T, Yanagihara K . 2000 Int. J. Oncol. 16: 119–124

  • Noel A, Gilles C, Bajou K, Devy L, Kebers F, Lewalle JM, Maquoi E, Munaut C, Remacle A, Foidart JM . 1997 Invasion Metastasis 17: 221–239

  • O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J . 1994 Cell 79: 315–328

  • O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, Folkman J, Moses MA . 1999 J. Biol. Chem. 274: 29568–29571

  • Patterson BC, Sang QA . 1997 J. Biol. Chem. 272: 28823–28825

  • Powe DG, Brough JL, Carter GI, Bailey EM, Stetler-Stevenson WG, Turner DR, Hewitt RE . 1997 Br. J. Cancer 75: 1678–1683

  • Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA . 2000 Proc. Natl. Acad. Sci. USA 97: 2202–2207

  • Prontera C, Mariani B, Rossi C, Poggi A, Rotilio D . 1999 Int. J. Cancer 81: 761–766

  • Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O . 1997 Clin. Cancer Res. 3: 1623–1628

  • Ritter LM, Garfield SH, Thorgeirsson UP . 1999 Biochem. Biophys. Res. Commun. 257: 494–499

  • Rowe TF, King LA, MacDonald PC, Casey ML . 1997 Am. J. Obstet. Gynecol. 176: 915–921

  • Rudolph-Owen LA, Matrisian LM . 1998 J. Mammary. Gland Biol. Neoplasia 3: 177–189

  • Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF . 1988 Cancer Res. 48: 5539–5545

  • Sehgal G, Hua J, Bernhard EJ, Sehgal I, Thompson TC, Muschel RJ . 1998 Am. J. Pathol. 52: 591–596

  • Shalinsky DR, Brekken J, Zou H, McDermott CD, Forsyth P, Edwards D, Margosiak S, Bender S, Truitt G, Wood A, Varki NM, Appelt K . 1999 Ann. NY Acad. Sci. 878: 236–270

  • Shofuda K, Moriyama K, Nishihashi A, Higashi S, Mizushima H, Yasumitsu H, Miki K, Sato H, Seiki M, Miyazaki K . 1998 J. Biochem. (Tokyo) 124: 462–470

  • Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z . 1999 Cell 98: 137–146

  • Steward WP, Thomas AL . 2000 Expert Opin. Investig. Drugs 9: 2913–2922

  • Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA . 1990 J. Biol. Chem. 265: 13933–13938

  • Stetler-Stevenson WG, Bersch N, Golde DW . 1992 FEBS Lett. 296: 231–234

  • Still K, Robson CN, Autzen P, Robinson MC, Hamdy FC . 2000 Prostate 42: 18–25

  • Uhr JW, Scheuermann RH, Street NE, Vitetta ES . 1997 Nat. Med. 3: 505–509

  • Valente P, Fassina G, Melchiori A, Masiello L, Cilli M, Vacca A, Onisto M, Santi L, Stetler-Stevenson WG, Albini A . 1998 Int. J. Cancer 75: 246–253

  • Visscher DW, Hoyhtya M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD, Fridman R . 1994 Int. J. Cancer 59: 339–344

  • Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, Shi YE . 1997 Oncogene 14: 2767–2774

  • Watanabe M, Takahashi Y, Ohta T, Mai M, Sasaki T, Seiki M . 1996 Cancer 77: 1676–1680

  • Wen W, Moses MA, Wiederschain D, Arbiser JL, Folkman J . 1999 Cancer Res. 59: 6052–6056

  • Witty JP, Lempka T, Coffey Jr RJ, Matrisian LM . 1995 Cancer Res. 55: 1401–1046

  • Wojtowicz-Praga SM, Dickson RB, Hawkins MJ . 1997 Invest. New Drugs 15: 61–75

  • Wylie S, MacDonald IC, Varghese HJ, Schmidt EE, Morris VL, Groom AC, Chambers AF . 1999 Clin. Exp. Metastasis 17: 111–117

  • Yamada E, Tobe T, Yamada H, Okamoto N, Zack DJ, Werb Z, Soloway PD, Campochiaro PA . 2001 Histol. Histopathol. 16: 87–97

  • Yamashita K, Suzuki M, Iwata H, Koike T, Hamaguchi M, Shinagawa A, Noguchi T, Hayakawa T . 1996 FEBS Lett. 396: 103–107

  • Ylisirnio S, Hoyhtya M, Turpeenniemi-Hujanen T . 2000 Anticancer Res. 20: 1311–1316

  • Yoshiji H, Gomez DE, Thorgeirsson UP . 1996 Int. J. Cancer 69: 131–134

  • Yoshiji H, Harris SR, Raso E, Gomez DE, Lindsay CK, Shibuya M, Sinha CC, Thorgeirsson UP . 1998 Int. J. Cancer 75: 81–87

  • Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y . 2000 Cancer Lett. 151: 81–86

  • Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W, Guillem JG . 1995 Clin. Cancer Res. 1: 899–906

Download references

Acknowledgements

This work was supported in part by grant CA68064-01 from National Institute of Health and grant DAMD17-96-1-6261 from US Department of Army Breast Cancer Research Program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y Eric Shi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, Y., Goldberg, I. & Shi, Y. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21, 2245–2252 (2002). https://doi.org/10.1038/sj.onc.1205291

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205291

Keywords

This article is cited by

Search

Quick links